Breast Implants and Breast Cancer

62
Editorial
Breast Implants and Breast Cancer

Davood Mehrabani1, Ail Manafi2*
1.
2.
Stem call and Transgenic

Technology Research Center,
Department of Pathology,
Shiraz university of Medical
sciences, Shiraz, Iran
Department of Plastic Surgery,
Tehran University of Medical
Sciences, Tehran, Iran
*Corresponding Author:
Ail Manafi, MD,
Associate Professor of Department
of Plastic Surgery,
Tehran University of Medical
Sciences, Tehran, Iran.
Tel: +98-21-88879942
Fax: +98-21-88879941
E-mail: a-manafi@sina.tums.ac.ir
Received: Apr. 2012
Accepted: May. 2012
www.wjps.ir /Vol.1/No.2/July 2012
Brest cancer is still the most common cancer among Female in

the world and is prevalent in different parts of Iran too.1 Silicone implants were applied for augmentation of the breast for
aesthetic goals or post-lumpectomy or mastectomy because of
malignancies in the tissue.2 The implant was shown to have inflammatory, fibro Proliferate response and connective tissue
disorders.3,4
In January issue of the journal in 2012, three articles were
published regarding breast cancer and breast implantation,
which are discussed in this paper. Mehrabani et al.5 describe
incidence of breast cancer in southern Iran with valuable information considering the risk factors. But it lacks data after
year 2006 while the face of this cancer may change by time.
Therefore, it is recommended that new information on breast
cancer from 2007 to 2012 are published in future issue with a
more detailed discussion of data in the same region as well as
other cities of the country.
In another study of this issue by Ravi-Kumar et al.6 on
anaplastic large cell lymphoma (ALCL) associated with breast
implants, they described a 42 years old woman with bilateral
breast augmentation for aesthetic purposes who had poor healing at the surgical site. Excisional biopsy revealed ALCL in the
tissue. Even it is a really good case report in their region but
this report lacks the treatment outcome of the patient and did
not explain why the patient was not transferred to an academic
metropolitan university hospital. It was more attractive for
readers if they presented any data on the frequency of breast
implants due to tissue malignancies in the country. Surgical
out-come was not so clear too. It should also be mentioned that
the authors did not reach a reasonable conclusion and comments for the readers.
In the third paper of that issue, Rajabiani et al.7 demonstrated a case of ALCL associated with breast implant. This
article provided good information on breast implants in malignancies for plastic surgeons while the report was new in their
locality like the previous report. They both efficiently discussed the presentations of the case and the therapeutic measures. This report lacks discussion on clinicopathological features of implant associated ALCL and have not denoted to the
treatment outcome of the patient even the conclusion and
comments cover the expectations of the readers.
Therefore, all breast tissues which are removed for implant
related complications should carefully be examined by a pathologist and they must be aware that this entity may easily be
misdiagnosed on histo- pathological examinations.
Mehrabani et al.
63
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
1
2
3
4
5
6
7
Mehrabani D, Tabei SZ, Hydari ST,Shamsnia SJ, Shokrpour N, Amini M, Masounmi SJ, Julaee
H, Farahmand M, Manafi A. Cancer occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J 2008;10:314-22.
Rosen WM, Rajkomer AK, Anavekar NS, Ashton MW. Post mastectomy breast reconstruction: A
history in evolution. Clin Breast Can 2009;9:145-54.
Spiera RF, Gibofsky A, Spira H. Silicone gel filled breast implants and connective tissue disorders, an overview. J Rheumatol 1994;21:239-45.
Brinton LA, Buckley LM, Dvorkinalubing JH, Colton T, Murray MC, Hoover R. Risk of connective tissue disorders among breast implant patients. Am J Epidemiol 1995;160:619-27.
Mehrabani D, Almasi A, Farahmad M, Ahrari Z, Rezainzadeh A, Mehrabani G, Talai AR. Incidence of breast cancer in Fars Province, southern Iran: A hospital-based study. World J Plast Surg
2012;1:16-21.
RaviKumar S, Sanaei D, Vasei M, Rainowitz I, Fekrazad MH. Anaplastic large cell lymphoma
associated with breast implants. World J Plast Surg 2012;1:30-35.
Rajabiani A, Arab H, Emami AH, Manafi A, Buzzes N, Suffer H. Anaplastic large cell lymphoma
associated with breast implant: A case report. World J plats Surg 2012;1:46-5.
www.wjps.ir /Vol.1/No.2/July 2012

Breast Implants and Breast Cancer

Uploaded by

Copyright:

Available Formats

Breast Implants and Breast Cancer

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Breast Implants and Breast Cancer

Uploaded by

Copyright:

Available Formats

62

Breast Implants and Breast Cancer

Stem call and Transgenic

www.wjps.ir /Vol.1/No.2/July 2012

Brest cancer is still the most common cancer among Female in

www.wjps.ir /Vol.1/No.2/July 2012

You might also like

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.